SSY GROUP(02005),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02005 SSY GROUP

Market Closed 04-02 16:08:21

2.500

-0.030

-1.19%

High2.550	Low2.480	Vol4.39M
Open2.550	D1 Closing2.530	Amplitude2.77%
Mkt Cap7.25B	Tradable Cap7.25B	Total Shares2.90B
T/O10.99M	T/O Rate0.15%	Tradable Shares2.90B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02005","market":"HK","secType":"STK","nameCN":"SSY GROUP","latestPrice":2.5,"timestamp":1775117301004,"preClose":2.53,"halted":0,"volume":4386000,"delay":0,"changeRate":-0.011857707509881346,"floatShares":2899000000,"shares":2899000000,"eps":0.1605,"marketStatus":"Market Closed","change":-0.03,"latestTime":"04-02 16:08:21","open":2.55,"high":2.55,"low":2.48,"amount":10991540,"amplitude":0.027668,"askPrice":2.5,"askSize":26000,"bidPrice":2.49,"bidSize":16000,"shortable":3,"etf":0,"ttmEps":0.1605,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775611800000},"marketStatusCode":7,"adr":0,"listingDate":1135008000000,"exchange":"SEHK","adjPreClose":2.53,"dividendRate":0.032,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"volumeRatio":0.3892576946316111,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02005","defaultTab":"news","newsList":[{"id":"2624563760","title":"Asian Market Spotlight: Promising Penny Stocks For April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2624563760","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624563760?lang=en_us&edition=fundamental","pubTime":"2026-04-03 12:05","pubTimestamp":1775189114,"startTime":"0","endTime":"0","summary":"As the Asian markets navigate through geopolitical tensions and energy market volatility, investors are keenly watching for opportunities that can weather these challenges. Penny stocks, though often seen as speculative, can offer unique growth potential when supported by strong financials. In this article, we explore several promising penny stocks in Asia that may combine value with long-term potential amidst current market conditions.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/retail/hkg-178/sa-sa-international-holdings-shares/news/asian-market-spotlight-promising-penny-stocks-for-april-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/retail/hkg-178/sa-sa-international-holdings-shares/news/asian-market-spotlight-promising-penny-stocks-for-april-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0082770016.USD","LU0516422366.SGD","LU1242518931.SGD","SGXZ58947870.SGD","SG9999014484.SGD","SG9999003826.SGD","BK1525","LU0164939612.USD","LU0516422440.USD","LU0979878070.USD","SGXZ27511609.SGD","SG9999000343.SGD","BK8040","SG9999000475.SGD","SG9999014492.USD","SG9999013486.USD","BK6081","SG9999004360.SGD","SG9999013478.USD","BK1502","BK6504","00178","SGXZ43160589.SGD","SG9999016042.SGD","LU0516423091.SGD","BK1601","BK1602","00241","SG9999002679.SGD","LU0620787316.HKD","BK1577","BK6065","BK1224","LU0082770016.SGD","LU1242518857.USD","SGXZ24219693.SGD","LU0516422952.EUR","SG9999013460.SGD","02005","LU0516423174.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138010297","title":"SSY Group Keeps Capital Structure Unchanged and Confirms Public Float Compliance for March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1138010297","media":"Bulletin Express","labels":["shareholding","SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138010297?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:47","pubTimestamp":1775036842,"startTime":"0","endTime":"0","summary":"SSY Group Limited filed its FF301 Monthly Return for the period ended 31 March 2026, showing a stable share capital structure with full adherence to Hong Kong Listing Rules. The authorised share...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623930884","title":"SSY Group Gets Bulk Drug Approval for Arthritis Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2623930884","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623930884?lang=en_us&edition=fundamental","pubTime":"2026-03-31 13:48","pubTimestamp":1774936127,"startTime":"0","endTime":"0","summary":"SSY Group's (HKG:2005) Upadacitinib was approved for registration by China's National Medical Products Administration to become a bulk drug for preparation on the market, according to a Tuesday Hong Kong bourse filing.The product is mainly used to treat rheumatoid arthritis and Crohn's disease.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4185","SSY","02005","LU2460026573.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623757623","title":"BRIEF-Ssy Group Says Upadacitinib Obtains Registration Approval From NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2623757623","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623757623?lang=en_us&edition=fundamental","pubTime":"2026-03-31 09:31","pubTimestamp":1774920664,"startTime":"0","endTime":"0","summary":"BRIEF-Ssy Group Says Upadacitinib Obtains Registration Approval From NMPAMarch 31 (Reuters) - SSY Group Ltd 2005.HK:UPADACITINIB OBTAINS REGISTRATION APPROVAL FROM CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATIONFurther company coverage: 2005.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40I1D8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005","LU2460026573.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102181242","title":"SSY GROUP's Upadacitinib Receives Approval as Active Pharmaceutical Ingredient in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1102181242","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102181242?lang=en_us&edition=fundamental","pubTime":"2026-03-31 09:17","pubTimestamp":1774919840,"startTime":"0","endTime":"0","summary":"SSY GROUP (02005) announced that its upadacitinib has been approved by China's National Medical Products Administration for registration as an active pharmaceutical ingredient in marketed...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU2460026573.USD","02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134616163","title":"SSY Group gains third NMPA approval for Upadacitinib bulk drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1134616163","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134616163?lang=en_us&edition=fundamental","pubTime":"2026-03-31 08:23","pubTimestamp":1774916597,"startTime":"0","endTime":"0","summary":"SSY Group Limited announced on 31 March 2026 that the National Medical Products Administration of China has approved the registration of the Group’s Upadacitinib active pharmaceutical ingredient for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623320708","title":"SSY Group wins China NMPA registration approval for Upadacitinib bulk drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2623320708","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623320708?lang=en_us&edition=fundamental","pubTime":"2026-03-31 08:07","pubTimestamp":1774915620,"startTime":"0","endTime":"0","summary":"SSY Group said China National Medical Products Administration granted registration approval for its Upadacitinib to be supplied as bulk drug for marketed preparations.Approval marks third such bulk-drug registration clearance for SSY’s PRC entities.Upadacitinib is a JAK-1 inhibitor used in autoimmune and inflammatory diseases, including rheumatoid arthritis and Crohn’s disease.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SSY Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 31, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL8f0PhK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005","LU2460026573.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623732071","title":"SSY Group - Upadacitinib Obtains Registration Approval From China National Medical Products Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2623732071","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623732071?lang=en_us&edition=fundamental","pubTime":"2026-03-31 08:06","pubTimestamp":1774915617,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40I1D8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","LU2460026573.USD","02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107428592","title":"SSY Group secures NMPA production approvals for Sodium Lactate Ringer’s Irrigation Solution and Bumetanide Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1107428592","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107428592?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:46","pubTimestamp":1774608373,"startTime":"0","endTime":"0","summary":"On 27 March 2026, SSY Group Limited announced that China’s National Medical Products Administration (NMPA) has granted production and registration approvals for two type 3 chemical drugs—Sodium...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622840030","title":"BRIEF-Ssy Group Obtains NMPA Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=2622840030","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622840030?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:35","pubTimestamp":1774607722,"startTime":"0","endTime":"0","summary":"BRIEF-Ssy Group Obtains NMPA ApprovalsMarch 27 (Reuters) - SSY Group Ltd 2005.HK:NMPA APPROVALS FOR DRUG PRODUCTION & REGISTRATION FOR SODIUM LACTATE RINGER'S IRRIGATION SOLUTION, BUMETANIDE INJECTIONFurther company coverage: 2005.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F0BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2460026573.USD","02005","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118108642","title":"SSY GROUP Secures Regulatory Approval for Two Pharmaceutical Products in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1118108642","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118108642?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:26","pubTimestamp":1774607192,"startTime":"0","endTime":"0","summary":"SSY GROUP (02005) announced that the company has obtained drug production registration approvals from China's National Medical Products Administration for Sodium Lactate Ringer's Irrigation Solution...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02005","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622406768","title":"SSY Group - Nmpa Approvals for Drug Production & Registration for Sodium Lactate Ringer's Irrigation Solution, Bumetanide Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2622406768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622406768?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:24","pubTimestamp":1774607052,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F0BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02005","BK1191","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622840662","title":"SSY Group obtains China NMPA approvals for Sodium Lactate Ringer's Irrigation Solution and Bumetanide Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2622840662","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622840662?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:22","pubTimestamp":1774606963,"startTime":"0","endTime":"0","summary":"SSY Group said China’s National Medical Products Administration approved production and registration for Sodium Lactate Ringer’s Irrigation Solution .The regulator also approved Bumetanide Injection , which the company said is classified as a type 3 chemical drug and passed consistency evaluation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SSY Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDLbJnkNr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2460026573.USD","02005","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622812600","title":"SSY Group's Profit Falls in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622812600","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622812600?lang=en_us&edition=fundamental","pubTime":"2026-03-27 13:05","pubTimestamp":1774587901,"startTime":"0","endTime":"0","summary":"SSY Group  booked HK$470.6 million in attributable profit for 2025, down from HK$1.06 billion in 2024, according to a Hong Kong bourse filing Friday.Earnings per share were HK$0.1605, compared with HK$0.3581 in the prior year.Revenue fell 28% year on year to HK$4.17 billion, figures showed.The company also declared a dividend of HK$0.03 per share, payable June 4 to shareholders of record on May 21.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2460026573.USD","BK1191","SSY","BK4185","02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167857629","title":"SSY Group Announces HK$0.03 Final Dividend for FY 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1167857629","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167857629?lang=en_us&edition=fundamental","pubTime":"2026-03-27 12:25","pubTimestamp":1774585510,"startTime":"0","endTime":"0","summary":"SSY Group Limited has declared a final ordinary dividend of HK$0.03 per share for the financial year ended 31 December 2025, according to the company’s latest announcement released on 27 March 2026....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192849473","title":"SSY Group Reports Fiscal Year Results: Net Profit Plummets 55.6% to HK$471 Million, Declares Final Dividend of HK$0.03","url":"https://stock-news.laohu8.com/highlight/detail?id=1192849473","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192849473?lang=en_us&edition=fundamental","pubTime":"2026-03-27 12:08","pubTimestamp":1774584533,"startTime":"0","endTime":"0","summary":"SSY GROUP announced its full-year financial results for the fiscal year ended December 31, 2025. During 2025, the group faced multiple pressures including shrinking demand, deepening policy reforms,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005","LU2460026573.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173717790","title":"SSY Group posts 2025 revenue of HK$4.17 billion, net profit drops 55.6%; trims annual dividend to HK$0.08","url":"https://stock-news.laohu8.com/highlight/detail?id=1173717790","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173717790?lang=en_us&edition=fundamental","pubTime":"2026-03-27 12:02","pubTimestamp":1774584178,"startTime":"0","endTime":"0","summary":"SSY Group released its audited results for the year ended 31 December 2025. Revenue and earnings   • Revenue fell 27.8% year on year to HK$4.17 billion, pressured by weaker demand for intravenous...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622981481","title":"SSY Group - FY Revenue RMB3,812 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622981481","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622981481?lang=en_us&edition=fundamental","pubTime":"2026-03-27 12:00","pubTimestamp":1774584057,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40E103:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","02005","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622887814","title":"SSY Group -  Final Dividend of HK$0.03 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2622887814","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622887814?lang=en_us&edition=fundamental","pubTime":"2026-03-27 12:00","pubTimestamp":1774584057,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40E103:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02005","LU2460026573.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192689040","title":"SSY GROUP (02005.HK) Secures NMPA Registration for Calcium Chloride Bulk Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1192689040","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192689040?lang=en_us&edition=fundamental","pubTime":"2026-03-19 16:42","pubTimestamp":1773909778,"startTime":"0","endTime":"0","summary":"SSY Group Limited announced that its Calcium Chloride product has received registration approval from the National Medical Products Administration of China, officially qualifying it as a bulk drug...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ssygroup.com.hk","stockEarnings":[{"period":"1week","weight":0.046},{"period":"1month","weight":0.0163},{"period":"3month","weight":-0.1259},{"period":"6month","weight":-0.1349},{"period":"1year","weight":-0.2366},{"period":"ytd","weight":-0.1166}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0253},{"period":"3month","weight":-0.0464},{"period":"6month","weight":-0.0746},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.","yearOnYearQuotes":[{"month":1,"riseRate":0.52381,"avgChangeRate":0.008314},{"month":2,"riseRate":0.52381,"avgChangeRate":0.02049},{"month":3,"riseRate":0.666667,"avgChangeRate":0.079064},{"month":4,"riseRate":0.52381,"avgChangeRate":0.034881},{"month":5,"riseRate":0.45,"avgChangeRate":0.00985},{"month":6,"riseRate":0.5,"avgChangeRate":0.067908},{"month":7,"riseRate":0.35,"avgChangeRate":-0.027819},{"month":8,"riseRate":0.35,"avgChangeRate":-0.017769},{"month":9,"riseRate":0.3,"avgChangeRate":-0.04678},{"month":10,"riseRate":0.45,"avgChangeRate":-0.001982},{"month":11,"riseRate":0.65,"avgChangeRate":0.086372},{"month":12,"riseRate":0.5,"avgChangeRate":-0.009169}],"exchange":"SEHK","name":"SSY GROUP","nameEN":"SSY GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SSY GROUP(02005),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SSY GROUP(02005) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SSY GROUP,02005,SSY GROUP股票,SSY GROUP股票老虎,SSY GROUP股票老虎国际,SSY GROUP行情,SSY GROUP股票行情,SSY GROUP股价,SSY GROUP股市,SSY GROUP股票价格,SSY GROUP股票交易,SSY GROUP股票购买,SSY GROUP股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SSY GROUP(02005),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SSY GROUP(02005) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}